We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.58B
AUM Growth
+$210M
Cap. Flow
+$71.1M
Cap. Flow %
4.5%
Top 10 Hldgs %
18.14%
Holding
221
New
32
Increased
92
Reduced
20
Closed
27

Top Buys

Rank Stock Value
1
ASND icon
Ascendis Pharma A/S
ASND
+$12.6M
2
PIII icon
P3 Health Partners
PIII
+$10.1M
3
MRVI icon
Maravai LifeSciences
MRVI
+$9.23M
4
NARI
Inari Medical, Inc. Common Stock
NARI
+$8.99M
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$8.85M

Top Sells

Rank Stock Value
1
AMRS
Amyris Inc.
AMRS
+$13M
2
DMTK
DermTech, Inc. Common Stock
DMTK
+$12.9M
3
OSH
Oak Street Health, Inc.
OSH
+$11.8M
4
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$9.93M
5
DNA icon
Ginkgo Bioworks
DNA
+$8.89M

Sector Composition

Rank Sector Weight
1 Healthcare 30.22%
2 Technology 18.11%
3 Financials 10.26%
4 Industrials 8.95%
5 Consumer Discretionary 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALV
176
DELISTED
KalVista Pharmaceuticals
KALV
– –
-217,389
Closed -$3.79M
LEVI icon
177
Levi Strauss
LEVI
$9.39B
– –
-36,240
Closed -$888K
LIND icon
178
Lindblad Expeditions
LIND
$2.22B
– –
-35,412
Closed -$517K
LNW
179
DELISTED
Light & Wonder
LNW
– –
-53,808
Closed -$4.47M
NVCR icon
180
NovoCure
NVCR
$1.91B
– –
-68,593
Closed -$7.97M
RL icon
181
Ralph Lauren
RL
$23.6B
– –
-8,321
Closed -$924K
STKL
182
DELISTED
SunOpta
STKL
– –
-193,144
Closed -$1.73M
TCBI icon
183
Texas Capital Bancshares
TCBI
$4.32B
– –
-144,667
Closed -$8.68M
PRMW
184
DELISTED
Primo Water Corporation
PRMW
– –
-209,186
Closed -$3.29M
SQSP
185
DELISTED
Squarespace, Inc.
SQSP
– –
-13,537
Closed -$523K
TLIS
186
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
– –
-65,939
Closed -$6.18M
EVBG
187
DELISTED
Everbridge, Inc. Common Stock
EVBG
– –
-54,569
Closed -$8.24M
DMTK
188
DELISTED
DermTech, Inc. Common Stock
DMTK
– –
-400,308
Closed -$12.9M
SPLK
189
DELISTED
Splunk Inc
SPLK
– –
-4,993
Closed -$723K
CELL
190
DELISTED
PhenomeX Inc. Common Stock
CELL
– –
-312,824
Closed -$6.12M
AMRS
191
DELISTED
Amyris Inc.
AMRS
– –
-946,366
Closed -$13M
OSH
192
DELISTED
Oak Street Health, Inc.
OSH
– –
-276,596
Closed -$11.8M
TPTX
193
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
– –
-149,425
Closed -$9.93M
4 5 6 7
8

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Nicholas Investment Partners held 221 positions worth $1.58B, up 15% from $1.37B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners deployed $71.1M of net new capital in Q4 2021, opening 32 new positions and adding to 92 existing holdings. Its largest new stake was P3 Health Partners: 21,075 shares worth $7.42M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 36% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Ginkgo Bioworks, an estimated $8.89M trimmed.

  • Nicholas Investment Partners's largest Q4 2021 buy was P3 Health Partners: 21,075 shares worth $7.42M.
  • Nicholas Investment Partners added most to Ascendis Pharma A/S in Q4 2021, an estimated $12.6M increase.
  • Nicholas Investment Partners's biggest Q4 2021 reduction was Ginkgo Bioworks, cutting an estimated $8.89M.
  • Nicholas Investment Partners fully exited Amyris Inc. in Q4 2021, selling an estimated $13M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $1.58B portfolio in Q4 2021.
  • Nicholas Investment Partners opened 32 new positions and closed 27 in Q4 2021.
  • Nicholas Investment Partners's portfolio value rose 15% quarter-over-quarter to $1.58B.

Based on Nicholas Investment Partners's 13F filing for Q4 2021, filed 14 Feb 2022.